GB1484329A - Ophthalmic and otic preparations - Google Patents

Ophthalmic and otic preparations

Info

Publication number
GB1484329A
GB1484329A GB55542/74A GB5554274A GB1484329A GB 1484329 A GB1484329 A GB 1484329A GB 55542/74 A GB55542/74 A GB 55542/74A GB 5554274 A GB5554274 A GB 5554274A GB 1484329 A GB1484329 A GB 1484329A
Authority
GB
United Kingdom
Prior art keywords
ophthalmic
otic preparations
benzylacrylonitrile
aminoalpha
sulphacetamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB55542/74A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of GB1484329A publication Critical patent/GB1484329A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GB55542/74A 1973-12-27 1974-12-23 Ophthalmic and otic preparations Expired GB1484329A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US42891873A 1973-12-27 1973-12-27

Publications (1)

Publication Number Publication Date
GB1484329A true GB1484329A (en) 1977-09-01

Family

ID=23700962

Family Applications (1)

Application Number Title Priority Date Filing Date
GB55542/74A Expired GB1484329A (en) 1973-12-27 1974-12-23 Ophthalmic and otic preparations

Country Status (22)

Country Link
JP (1) JPS5830284B2 (xx)
AT (1) AT345448B (xx)
BE (1) BE823952A (xx)
CA (1) CA1031263A (xx)
CH (1) CH616413A5 (xx)
CY (1) CY1103A (xx)
DE (1) DE2461570C3 (xx)
DK (1) DK684474A (xx)
ES (1) ES433357A1 (xx)
FI (1) FI374974A (xx)
FR (1) FR2255909B1 (xx)
GB (1) GB1484329A (xx)
HK (1) HK3081A (xx)
IE (1) IE40344B1 (xx)
IL (1) IL46353A (xx)
IN (1) IN140139B (xx)
KE (1) KE3103A (xx)
MC (1) MC1044A1 (xx)
MY (1) MY8400041A (xx)
NL (1) NL7416636A (xx)
SE (1) SE421996B (xx)
ZA (1) ZA748179B (xx)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0037043A1 (en) * 1980-03-21 1981-10-07 The Wellcome Foundation Limited Stabilised ophthalmic formulation
US11096923B2 (en) 2016-08-16 2021-08-24 University Of Rochester Pharmaceutical composition containing polymyxin B/trimethoprim based therapeutics

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2079994B1 (es) * 1992-10-07 1996-08-01 Cusi Lab Formulacion farmaceutica a base de polimixina-trimetoprim y un agente antiinflamatorio para su utilizacion topica oftalmica y otica.

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0037043A1 (en) * 1980-03-21 1981-10-07 The Wellcome Foundation Limited Stabilised ophthalmic formulation
US11096923B2 (en) 2016-08-16 2021-08-24 University Of Rochester Pharmaceutical composition containing polymyxin B/trimethoprim based therapeutics

Also Published As

Publication number Publication date
KE3103A (en) 1981-02-13
DE2461570A1 (de) 1975-07-10
ZA748179B (en) 1976-07-28
JPS5830284B2 (ja) 1983-06-28
IE40344B1 (en) 1979-05-09
JPS5095418A (xx) 1975-07-29
DE2461570C3 (de) 1982-05-19
MC1044A1 (fr) 1975-10-10
FR2255909B1 (xx) 1978-06-30
CH616413A5 (en) 1980-03-31
NL7416636A (nl) 1975-07-01
IE40344L (en) 1975-06-27
HK3081A (en) 1981-01-30
ATA1034074A (de) 1978-01-15
AT345448B (de) 1978-09-11
DE2461570B2 (de) 1981-06-04
FR2255909A1 (xx) 1975-07-25
BE823952A (fr) 1975-06-27
FI374974A (xx) 1975-06-29
AU7696174A (en) 1976-07-01
DK684474A (xx) 1975-09-08
CY1103A (en) 1981-09-11
IL46353A0 (en) 1975-04-25
IN140139B (xx) 1976-09-18
CA1031263A (en) 1978-05-16
SE7416310L (sv) 1975-06-30
IL46353A (en) 1977-12-30
MY8400041A (en) 1984-12-31
SE421996B (sv) 1982-02-15
ES433357A1 (es) 1977-04-01

Similar Documents

Publication Publication Date Title
ES473451A1 (es) Un procedimiento para la preparacion de derivados de imida- zol.
IL103844A0 (en) Indolopyrrolo-carbazole derivatives,their preparation and pharmaceutical compositions containing them
ES8200665A1 (es) Procedimiento para la preparacion de sulfonilureas
ES470155A1 (es) Un procedimiento para la obtencion de derivados de espiroa- mina
ES8202784A1 (es) Un procedimiento para la preparacion de derivados de aminas secundarias.
ES8107216A1 (es) Procedimiento para la preparacion de sulfonilureas
DE3169480D1 (en) Trisubstituted pyrimido(5,4-d)pyrimidines, their preparation and medicaments containing them
GB1484329A (en) Ophthalmic and otic preparations
GB1153578A (en) Phenyl-Isopropylamine Derivatives
ES480113A1 (es) Procedimiento para la preparacion de nuevos derivados de 2- iminoimidazolidina.
ES8200119A1 (es) Un procedimiento para la preparacion de un derivado de 2-de soxi-fortimicina a o b2-sustituidos.
ES8308551A1 (es) Procedimiento para la preparacion de derivados de tiazolina.
ES8401946A1 (es) Procedimiento para la preparacion de sulfonilureas.
ES8800156A1 (es) Procedimiento para preparar nuevos derivados 3-piridilmetilnaftilicos
ES8403911A1 (es) Procedimiento de preparacion de mononitratos de 1.4,3.6- dianhidro-hexito sustituidos en 2-0 y 5-0
ES8200684A1 (es) Procedimiento para la preparacion de sulfonilureas
ES473900A1 (es) Procedimiento para la obtencion de 1,3,4,14b-tetrahidro-2h, 1oh-pirazino-1,2-a-pirrolo-2,1-c-1,4-benzodiazepinas.
ES8107219A1 (es) Procedimiento para la preparacion de sulfonilureas
GB1420780A (en) Medicinal preparation of treatment of malignant neoplasms mostly hemoblastoses and chorionepithelioma
ES8101053A1 (es) Procedimiento mejorado para la preparacion de sulfonilureas
GB1073521A (en) Indole derivatives
ES2018404A6 (es) Procedimiento para preparar nuevas 2-metoxicarbonil sustituido-n, n'-di-(trimetoxibenzoil)-piperazinas.
ES8704463A1 (es) Procedimiento para preparar 2-(n-alquinil-n-fenilamino)-imidazolinas
IE39639L (en) Preparation of n-substituted cycloserine derivatives.
ES8200328A1 (es) Un procedimiento para la preparacion de derivados peptidicos

Legal Events

Date Code Title Description
416 Proceeding under section 16 patents act 1949
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee